Introduction: The significant therapeutic potential of the advanced therapies (ATs) has
predetermined the increased interests in their development mainly in the context of rare …

Background Pharmaceutical expenditures (PE) are increasing worldwide, raising concerns
about sustainability. However, the current price index provides an incomplete picture of this …

Biomaterials have emerged as pivotal components in various fields, ranging from
biomedical engineering to regenerative medicine. However, the integration of biomaterials …

Depression leads to a significant economic and financial burden, which determines the
need for implementation of screening programs involving community pharmacists. The aim …

Provision of the latest innovative and advanced therapies for rare diseases (RDs) patients,
following the international therapeutic recommendations, is crucial and necessary for both …

Introduction This overview paper aims at summarizing and analyzing the available literature
on healthcare system organization and pricing policies of 11 European countries, comparing …

Introduction: Despite clinical trials, there are still no approved specific therapies or any
vaccine against COVID-19. The only option available is using investigational drugs for …

Background and objectives Major psychiatric disorders require prolonged use of
psychotropic medications and pose a significant economic burden. The purpose of the study …

Представеният монографичен труд на доц. Цветкова е посветен на много актуален
проблем в съвременното здравеопазване, а именно как системата на здравеопазване …

The study aims to present a general overview of the process of HTA for biotechnology
medicines in Bulgaria with special emphasis on hospital practice. It is a regulatory and …